Conseil Cri de la santé et des services sociaux de la Baie James COORDONNATEUR(TRICE) - FOYER POUR LES AÎNÉS (M-2425-0010) Numéro de référence : CCAD-24-1379 Numéro au registre de poste : 0143 Territoire de l'emploi : Chisasibi Site :...
tolérancement géométrique applicable Connaissance des outils informatique MS Outlook et Office ainsi que du langage... and the applicable geometric tolerance Knowledge of MS Outlook and Office IT tools as well as CMM programming language...
Top dividend yield stocks: Coal India and Gujarat State Fertilisers & Chemicals are on Religare Broking's list of top 10 dividend yield stocks. Continue Reading »
Budget 2024: Hemal Shah of Torus ORO PMS has suggested L&T, HDFC Bank, Canfin Homes, and Oil India ahead of the upcoming Union Budget saying that the stocks can benefit most out of the policy announcements. Continue Reading »
Indian benchmark indices continue bullish streak, fueled by potential rate cut by US Federal Reserve, FPI inflows, and rally in banking and IT stocks. Nifty 50 ends week with 1.30% gain, hitting new all-time high. Mid- and small-cap stocks also show strong performance. Continue Reading »
According to data collected from the Bombay Stock Exchange (BSE) website, the Emcure Pharmaceuticals IPO issue was oversubscribed 67.86 times. Qualified institutional buyers (QIB), non-institutional investors (NII), and retail investors showed strong bids on the third day. Continue Reading »
Anand Rathi recommends 2 'emerging picks' for July 2024, focusing on CONCOR and ideaForge Technology with a time horizon of 30-90 days. Continue Reading »
Stock Market Today: Sun Pharma share price has risen almost 25% year to date. The news flow recently has remained around regulatory actions by the USFDA for Dadra nd Halol plant Should you Buy , Sell or Hold the stock? Continue Reading »
Bansal Wire IPO subscription status shows overwhelming response from investors, with 59.57 times subscription. QIBs, NIIs, and retail investors actively participated. Price band set at ₹243-256 per share. Analysts bullish on long-term prospects, expecting decent listing gains of over 25%. Continue Reading »